Rep. Waxman To FDA: Rely On Inspectors, Not Industry, For Compliance
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA should rely more on the recommendations of its inspectors and less on regulated industry to ensure compliance, Rep. Henry Waxman (D-Calif.) said
You may also be interested in...
FDA Commissioner Choice Appears To Be Crawford
The White House appears to have settled on Acting Commissioner Lester Crawford to fill the agency's top slot permanently. Crawford is understood to have met with President Bush Jan. 27.
GOP Bioterror Bill Includes Vaccine Liability Reform, FDA "Rapid-Action" Team
Senate leadership biodefense bill includes several provisions that could have broad implications for the vaccine market. S 3 would grant "fast track" status to all "second generation" vaccines, and includes an FDA preemption clause.
FDA May Need To Reduce Timeframe For Inspecting Flu Vaccine Facilities, Rep. Davis Says
House Government Reform Committee Chairman Tom Davis (R-Va.) indicated interest in revising FDA's procedures regarding inspection of flu vaccine manufacturing facilities in light of the current supply shortage